论文部分内容阅读
目的临床观察MRI引导下125I粒子植入治疗颅内胶质瘤的疗效。方法选取我院在2010年3月至2011年3月间,所诊断的颅内胶质瘤的患者30例,对患者的采用MRI引导下125I粒子植入治疗,观测其疗效以及并发症发生率,来做一个比较详细的回顾性的分析。结果125I粒子植入2个月以后进行复查可知:CR的为15个,PR的为5个,NC的为3个,PD的为2个,总有效率为83.3%。在两个月时的随访时,粒子所移位的有2例,粒子丢失的有1例。结论 MRI引导下125I粒子植入治疗颅内胶质瘤的近期临床的疗效非常好,是一个微创有效,安全可靠的治疗颅内胶质瘤的新方法。
Objective To observe the effect of MRI-guided 125I seed implantation in the treatment of intracranial gliomas. Methods Thirty patients with intracranial gliomas diagnosed in our hospital from March 2010 to March 2011 were enrolled in this study. MRI-guided 125I seed implantation was performed on patients. The therapeutic effect and complication rate were observed , To do a more detailed retrospective analysis. Results After 125I seeds were implanted for 2 months, 15 CRs, 5 PRs, 3 NCs and 2 PDs had a total effective rate of 83.3%. At two months of follow-up, there were 2 cases of particle displacement and 1 case of particle loss. Conclusion The MRI-guided 125I particle implantation in the treatment of intracranial gliomas has a very good clinical effect in the near future. It is a safe, reliable and minimally invasive method for the treatment of intracranial gliomas.